Oculomotor nerve palsy as a preceding symptom of adult sporadic Burkitt lymphoma: A case report and review of the literature

about

Oculomotor nerve palsy as a preceding symptom of adult sporadic Burkitt lymphoma: A case report and review of the literature

Item

http://www.wikidata.org/entity/Q39270336

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Oculomotor nerve palsy as a pr ...... t and review of the literature

@en

Oculomotor nerve palsy as a pr ...... and review of the literature.

@nl

type

Item

label

Oculomotor nerve palsy as a pr ...... t and review of the literature

@en

Oculomotor nerve palsy as a pr ...... and review of the literature.

@nl

prefLabel

Oculomotor nerve palsy as a pr ...... t and review of the literature

@en

Oculomotor nerve palsy as a pr ...... and review of the literature.

@nl

P1476

Oculomotor nerve palsy as a pr ...... t and review of the literature

@en

P2093

Luyin Ding

http://www.w3.org/2001/XMLSchema#string

Weiqin Wang

http://www.w3.org/2001/XMLSchema#string

Xian Li

http://www.w3.org/2001/XMLSchema#string

Xiaohong Zhang

http://www.w3.org/2001/XMLSchema#string

Yun Liang

http://www.w3.org/2001/XMLSchema#string

P2860

The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997

CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies.

Central nervous system disease in hematologic malignancies: historical perspective and practical applications.

Molecular biology of Burkitt's lymphoma.

InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions.

Adult Burkitt leukemia and lymphoma.

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.

Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.

Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents.

P304

1315-1318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.5583

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28454254

http://www.w3.org/2001/XMLSchema#string

P921

Burkitt lymphoma

P932

5403323

http://www.w3.org/2001/XMLSchema#string